0001779735-21-000002.txt : 20211112 0001779735-21-000002.hdr.sgml : 20211112 20211112151823 ACCESSION NUMBER: 0001779735-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211112 DATE AS OF CHANGE: 20211112 EFFECTIVENESS DATE: 20211112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vascular Perfusion Solutions, Inc. CENTRAL INDEX KEY: 0001779735 IRS NUMBER: 813798785 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-420931 FILM NUMBER: 211402902 BUSINESS ADDRESS: STREET 1: 503 AVENUE A, SUITE 1115 CITY: SAN ANTONIO STATE: TX ZIP: 78215 BUSINESS PHONE: 210-977-0191 MAIL ADDRESS: STREET 1: 503 AVENUE A, SUITE 1115 CITY: SAN ANTONIO STATE: TX ZIP: 78215 D 1 primary_doc.xml X0708 D LIVE 0001779735 Vascular Perfusion Solutions, Inc. 312 Pearl Parkway Building 5, Suite 5104 SAN ANTONIO TX TEXAS 78215 210-977-0191 DELAWARE None None Corporation true 2016 Tom DeBrooke 312 Pearl Parkway Building 5, Suite 5104 San Antonio TX TEXAS 78215 Executive Officer Director Leon Bunegin 312 Pearl Parkway Building 5, Suite 5104 San Antonio TX TEXAS 78215 Executive Officer Director Mark Muller 312 Pearl Parkway Building 5, Suite 5104 San Antonio TX TEXAS 78215 Executive Officer Director Klaus Weiswurm 312 Pearl Parkway Building 5, Suite 5104 San Antonio TX TEXAS 78215 Director Celia Jairala 312 Pearl Parkway Building 5, Suite 5104 San Antonio TX TEXAS 78215 Director Paul Perry 312 Pearl Parkway Building 5, Suite 5104 San Antonio TX TEXAS 78215 Executive Officer Biotechnology Decline to Disclose 06b false 2021-10-29 false true false 0 3000000 850000 2150000 false 2 0 0 0 A portion of the proceeds will be used to pay compensation to some of the Executive Officers named in response to item 3 above. false Vascular Perfusion Solutions, Inc. Tom DeBrooke Tom DeBrooke CEO 2021-11-11